|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2009-06-23 Option Award |
2009-06-23 6:42 pm | 2010-06-23 2019-06-23 |
ALLOS THERAPEUTICS INC | ALTH | LATTS JEFFREY (Director) | 20,000 | $7.33 | 20,000 (Direct) | View |
| 2008-06-24 Option Award |
2008-06-26 6:08 pm | 2009-06-24 2018-06-24 |
ALLOS THERAPEUTICS INC | ALTH | LATTS JEFFREY (Director) | 20,000 | $6.3 | 20,000 (Direct) |
View |
| 2007-04-25 Option Award |
2007-04-26 2:07 pm |
2008-04-25 2017-04-25 | ALLOS THERAPEUTICS INC | ALTH | LATTS JEFFREY (Director) | 25,000 | $6.47 | 25,000 (Direct) |
View |
| 2006-12-08 Option Award |
2006-12-12 7:09 pm | 2007-12-08 2016-12-07 |
EXELIXIS INC | EXEL | LATTS JEFFREY (Executive VP, Development) | 100,000 | $8.99 | 100,000 (Direct) |
View |
| 2005-12-12 Option Award | 2005-12-14 9:20 pm |
2006-12-12 2015-12-11 | EXELIXIS INC | EXEL | LATTS JEFFREY (Sr VP, Chief Medical Officer) | 300,000 | $8.9 | 300,000 (Direct) | View |
| 2004-12-13 Option Award | 2004-12-15 4:45 pm | 2005-12-13 2014-12-12 | EXELIXIS INC | EXEL | LATTS JEFFREY (Sr VP, Chief Medical Officer) | 100,000 | $8.92 | 100,000 (Direct) |
View |
| 2003-12-10 Option Award |
2003-12-12 5:38 pm | 2004-12-10 2013-12-10 |
EXELIXIS INC | EXEL | LATTS JEFFREY (Sr VP, Chief Medical Officer) | 115,000 | $6.15 | 380,000 (Direct) | View |
|
© 2005-2010 SecForm4.Com All rights reserved. Archives: 2010 2009 2008 2007 2006 2005 ... Sun, 21 Mar 2010 00:06:49 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |